4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-007690
EVP and General Counsel sold 5,140 shares at $9.45 ($48,590)
- EVP and General Counsel acquired 35,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP and General Counsel | 2025-02-22 | Grant or award 10b5-1 | +35,000 | 91,973 | D | ||
| de Verneuil Vanina EVP and General Counsel | 2025-02-24 | Sale 10b5-1 | −5,140 | $9.45 | $48,590 | 86,833 | D |
| Derivatives | |||||||
| de Verneuil Vanina EVP and General Counsel | 2025-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +70,000 | 70,000 | D | ||
| Open-market sales · 5,140 sh · avg $9.45 · $48,590 | |||||||
Loading xslF345X05/wk-form4_1740515688.xml…